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Editorial Comment 
Kawasaki Disease: Unsafe at 
Any Age?* 
BERTRAND A. ROSS, MD, FACC 
Norfolk, Virginia 
With the efforts by Paridon et al. (1) in this issue, and Hijazi et 
al. (2) in the December 1994 issue, of the Journal, medicine 
now begins the evaluation of the long-term sequelae of Ka- 
wasaki disease. Recent reports by both Ishiwata et al. (3) and 
Kato et al. (4) highlight 5 and 21 patients, respectively (all 
asymptomatic a minimum of 10 years), who developed symp- 
toms of ischemic oronary artery disease 10 to 20 years after a 
suspected episode of Kawasaki disease. By 1986 >80,000 
patients in Japan had been diagnosed as having Kawasaki 
disease (5). Given the time since the first description in 1967 
we will soon see adults who had Kawasaki disease as children 
who are now entering their 4th and 5th decade of life. Akagi et 
al. (6) reported an almost 14% incidence of coronary aneu- 
rysms in patients with the disease from 1974 to 1991 with 41% 
persistence at 5 years. Similar to the baby boomers, this group 
of children with previous Kawasaki disease will work its way 
into adulthood and bring the potential for long-term sequelae 
from the disease. This is especially true of the first group who 
generally did not have the benefit of adequate treatment. 
Salicylate and more recently (and impressively) immunoglob- 
ulin therapy seem to decrease the incidence and severity of 
coronary artery aneurysms. (6) 
However, the report by Paridon et al. (1) in this issue of the 
Journal may raise the stakes and the level of concern because 
they show perfusion abnormalities with exercise in 25 (54%) of 
46 patients with a previous history of Kawasaki disease. All 
patients were without coronary artery stenosis, and coronary 
artery aneurysm was present in only 8 (17%) of 46 patients. In 
their study, Paridon et al. evaluated three groups of patients 
with previous Kawasaki disease: those without demonstrable 
coronary involvement, those with "resolved" coronary involve- 
ment and those with continued involvement. Corroborating 
the previous findings of others, Paridon et al. found a disparity 
in the incidence of positive study findings by stress electrocar- 
diography compared with those of stress nuclear imaging: Only 
5 (11%) of 46 patients had ST segment changes with exercise 
versus 25 (54%) of 46 with exercise-induced perfusion defects 
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identified by technetium-99m single-photon emission com- 
puter tomographic (SPECT) imaging. Surprisingly, 10 (37%) 
of 27 patients with "normal" coronary arteries and 7 (64%) of 
11 with "resolved" coronary abnormalities showed reversible 
perfusion defects. In addition, all eight patients with aneu- 
rysms had perfusion defects (seven reversible). Although the 
follow-up period was as short as 6 months after the active stage 
of the illness, all but two of the patients with perfusion 
abnormalities were ->3 years removed from the early event. 
Unlike most previous reports, in the Paridon et al. study the 
patients with coronary artery aneurysms had no coronary 
artery stenosis but did have perfusion defects. Unfortunately, 
interpretation of the SPECT imaging results was not per- 
formed in a completely blinded manner. However, 20 case 
results were read by two reviewers in blinded manner, and 
the readings were concordant in 19 of 20. In addition, although 
the localization of the perfusion defects was rather broad, 
there was good correlation of perfusion defects with areas of 
known or previous coronary artery involvement. A completely 
blinded interpretation, if at all possible given the infrequent 
nature of the study in pediatric ardiology, would have helped 
make a much stronger case. 
The study by Hijazi et al. (2) in the December 1994 issue of 
the Journal also deals with myocardial blood flow changes 
during exercise in patients who have had previous Kawasaki 
disease, but the findings are somewhat different. They highlight 
the finding that most of the vascular territories upplied by 
coronary arteries with aneurysms had normal perfusion with 
exercise (72%). In addition, of the five territories with perfu- 
sion defects, three were supplied by coronary arteries with both 
aneurysms and stenoses. As a group, these 11 patients all had 
demonstrable aneurysms, with 45% showing abnormal SPECT 
study results compared with 100% of such patients in the study 
by Paridon et al. (1). 
The reason for these differences is unclear but may be 
related to the methodology of the stress test itself, the SPECT 
interpretation r previous treatment. The methodology in the 
study by Hijazi et al. (2) focused on stress echocardiography 
and, therefore, was not able to evaluate the degree of cardio- 
respiratory stress produced by exercise, except for maximal 
heart rate. It is possible that their patients quit more as a result 
of leg fatigue than from achieving the maximal cardiorespira- 
tory threshold for exercise. However, six of eight patients who 
may have produced a submaximal effort, as reported by 
Paridon et al., had abnormal perfusion during exercise. 
Roughly half of the SPECT interpretations i  the Paridon et al. 
study, whereas all of the rest evaluations in the Hijazi et al. 
study, were performed in blinded manner. However, it is 
unclear whether the exercise SPECT interpretations in that 
study (2) were performed in blinded manner as well. Because 
therapy, especially with immunoglobulin, has shown to de- 
crease myocardial and coronary disease (7), the differences in 
treatment may also have altered the study results. Over 50% of 
the patients in the study by Hijazi et al. (2) were treated with 
immunoglobulins (6of 11), whereas no treatment history was 
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available from the data provided by Paridon et al. (1). Al- 
though the investigation by Hijazi et al. (2) did not show an 
association between aneurysm size and abnormal f ow, there 
was an increased incidence of abnormal perfusion by stress 
nuclear imaging, which reinforces the Paridon et al. findings 
and the need for at least heightened awareness if not concern. 
Coronary pathologic analysis. Pathologic analysis by Fuji- 
wara et al. (7) documented four stages in the pathology of the 
coronary arteries. Acute inflammatory changes are seen in the 
first 6 to 9 days in the intima and advertitia. This progresses tothe 
media and becomes panvascular by 12 to 25 days. Subsequently, 
aneurysms are seen by 28 to 32 days. Marked fibrous intimal 
thickening with recanalization, thrombi and severe stenosis are 
seen after 40 days. Aneurysms have been reported within the first 
2 weeks of the early phase of the disease. Rather than returning 
to normal, these aneurysms show normal umen size yet have a 
markedly increased intima with fibrosis. The aneurysm appears to 
fill in with fibrosis of thc intima, producing what appears by 
angiography tobe a normal caliber lumen yet is in reality a stiffer, 
less elastic vessel segment. 
Sequelae from Kawasaki disease. Early sequelae. Myocar- 
ditis with arteritis occurs, involving over time all layers of the 
coronary arteries, which may lead to massive fibrosis of the 
myocardium, endocardial fibroelastosis and coagulation necro- 
sis of the myocardium inthe most severe cases (8). In survivors 
this myocardial fibrosis will persist and may conceivably play a 
role in the pathogenesis of the disease into adulthood. 
Late sequelae 
1. Coronary artery aneurysms with frequently associated cor- 
onary artery stenosis arc the main players to date in the long-term 
effects of Kawasaki disease. The larger the aneurysm the worse 
the pathology generally and the less the regression. These defects 
will represent a fixed obstruction with stenosis at either end of the 
aneurysm inthe majority of patients. The stenosis associated with 
the aneurysms has been suggested to be due to the endothelial 
response to sheer forces from flow into and out of the aneurysm 
(9). Flow characteristics through the aneurysm may actually 
promote progression of any stenosis. 
2. Resolved aneurysms may be resolved in that they are no 
longer aneurysmal, but the coronary artery itself may not be 
completely normal. These may represent fixed lumen diame- 
ters with less elasticity and an inability to respond to changes in 
myocardial perfusion eeds. 
3. Small and mid-sized coronary arteries have been shown 
to be involved early. The rash that occurs in Kawasaki disease 
has been suggested to represent a perivasculitis and vasculitis 
of the microvessels and small arteries. A panvasculitis has been 
frequently detected where branches diverge from the three 
major coronary arteries. There is some evidence that there may 
also be a long-term alteration in the smaller coronary arteries 
as a result of the disease. Fibrosis of the perivascular tissue has 
been shown later than 40 days after onset of the disease (8). 
These vessels may have a long-term defect in their ability to 
vasodilate appropriately, leading to a decreased coronary 
reserve. Hamaoka et al. (9) have demonstrated in normal 
children ahigher coronary vascular esistance and less efficient 
coronary blood flow. Therefore, differences in coronary flow, 
as evidenced by technetium-99m SPECT imaging may not be 
as readily apparent in the young child as those in the adult. 
Paridon et al. (1) and others may have identified an inability of 
these vessels to vasodilate appropriately during exercise. This 
abnormality appears in some ways similar to perfusion defects 
seen by nuclear imaging during exercise stress testing in 
patients with hypertension and left ventricular hypertrophy. 
These patients have been shown to have abnormal muscula- 
ture in the coronary arteries yet are asymptomatic for coronary 
ischemia. Because the perfusion defects in such patients 
appear to respond to calcium channel blockers, it would be 
interesting and informative to determine the response to 
calcium channel blockers in patients with previous Kawasaki 
disease who have no history of aneurysms but who have 
abnormal findings on perfusion scans during exercise but 
"normal" coronary arteries. 
Atherosclerosis anyone? The issue of atherosclerosis ec- 
ondary to previous damage of the coronary arteries from 
Kawasaki disease has to be considered. Coronary arteritis can 
produce ndothelial damage and lead to entry of lipid into the 
vessel wall. Because we do not yet have experential data on 
patients with Kawasaki disease we must look to other diseases 
that produce a vasculitis. The arteritis from systemic lupus 
erythematosus, which is transient (like Kawasaki disease) but 
recurrent, may increase the rate of atheromatous coronary 
artery disease, but the answer is not clear (10). Orthotopic 
cardiac transplantation also produces a coronary arteritis and 
a type of atherogenic disease, but this is a chronic, ongoing 
vasculitis and is not similar to the pathology seen with Ka- 
wasaki disease, which is generally acute. The coronary occlu- 
sion in this group of patients is much different from that seen 
in those with Kawasaki disease. Although there is no clear 
evidence to predict premature atherosclerotic coronary artery 
disease in patients with resolved aneurysms, given the meth- 
odology of healing there may be some increased risk. In those 
patients without any previous coronary aneurysms, one would 
hope that their risk would be similar to that of the general 
population. 
A word of caution. We must keep in mind that these studies 
detail an abnormal laboratory finding in asymptomatic pa- 
tients, some of whom have no detected anatomic abnormality. 
This may represent a physiologic abnormality with clinical 
significance but one that has not been proved. Further esearch 
in to the outcomes of large numbers of these patients will hell: 
the practitioner todecide the relative predictive value of these 
test results on an individual patient basis. 
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